Mak EK - Search Results

1

Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.

de la Fuente-Fernández R, Pal PK, Vingerhoets FJ, Kishore A, Schulzer M, Mak EK, Ruth TJ, Snow BJ, Calne DB, Stoessl AJ. de la Fuente-Fernández R, et al. Among authors: mak ek. J Neural Transm (Vienna). 2000;107(1):49-57. doi: 10.1007/s007020050004. J Neural Transm (Vienna). 2000. PMID: 10809403

2

Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.

de la Fuente-Fernández R, Schulzer M, Mak E, Calne DB, Stoessl AJ. de la Fuente-Fernández R, et al. Brain. 2004 Apr;127(Pt 4):888-99. doi: 10.1093/brain/awh102. Epub 2004 Feb 11. Brain. 2004. PMID: 14960500

3

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism.

Vingerhoets FJ, Snow BJ, Lee CS, Schulzer M, Mak E, Calne DB. Vingerhoets FJ, et al. Ann Neurol. 1994 Nov;36(5):759-64. doi: 10.1002/ana.410360512. Ann Neurol. 1994. PMID: 7979222

4

Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.

Kishore A, Nygaard TG, de la Fuente-Fernandez R, Naini AB, Schulzer M, Mak E, Ruth TJ, Calne DB, Snow BJ, Stoessl AJ. Kishore A, et al. Neurology. 1998 Apr;50(4):1028-32. doi: 10.1212/wnl.50.4.1028. Neurology. 1998. PMID: 9566390

5

Age-dependent decline of dopamine D1 receptors in human brain: a PET study.

Wang Y, Chan GL, Holden JE, Dobko T, Mak E, Schulzer M, Huser JM, Snow BJ, Ruth TJ, Calne DB, Stoessl AJ. Wang Y, et al. Synapse. 1998 Sep;30(1):56-61. doi: 10.1002/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J. Synapse. 1998. PMID: 9704881

6

PET demonstrates reduced dopamine transporter expression in PD with dyskinesias.

Troiano AR, de la Fuente-Fernandez R, Sossi V, Schulzer M, Mak E, Ruth TJ, Stoessl AJ. Troiano AR, et al. Neurology. 2009 Apr 7;72(14):1211-6. doi: 10.1212/01.wnl.0000338631.73211.56. Epub 2008 Nov 19. Neurology. 2009. PMID: 19020294

7

Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.

Lee CS, Schulzer M, de la Fuente-Fernández R, Mak E, Kuramoto L, Sossi V, Ruth TJ, Calne DB, Stoessl AJ. Lee CS, et al. Arch Neurol. 2004 Dec;61(12):1920-5. doi: 10.1001/archneur.61.12.1920. Arch Neurol. 2004. PMID: 15596613

8

Treatment for the progression of Parkinson's disease.

Calne D, Schulzer M, Mak E, Stoessl AJ. Calne D, et al. Lancet Neurol. 2005 Apr;4(4):206. doi: 10.1016/S1474-4422(05)70026-0. Lancet Neurol. 2005. PMID: 15778097 No abstract available.

9

PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.

Adams JR, van Netten H, Schulzer M, Mak E, Mckenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ. Adams JR, et al. Brain. 2005 Dec;128(Pt 12):2777-85. doi: 10.1093/brain/awh607. Epub 2005 Aug 4. Brain. 2005. PMID: 16081470

10

Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function.

Troiano AR, Schulzer M, de la Fuente-Fernandez R, Mak E, McKenzie J, Sossi V, McCormick S, Ruth TJ, Stoessl AJ. Troiano AR, et al. Synapse. 2010 Feb;64(2):146-51. doi: 10.1002/syn.20708. Synapse. 2010. PMID: 19852071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters